Sales & Marketing Views & Analysis

Views & Analysis

MSD’s David Peacock on moving UK healthcare forward

David Peacock has worked across the world for MSD and other companies, and has now taken the helm of MSD’s UK & Ireland operations.

Views & Analysis

The enduring innovation and behaviour changes from COVID-19

The COVID-19 crisis has accelerated the shift to a more resilient, agile and innovative digitally-enabled world within healthcare and pharma.

Views & Analysis

Alnylam’s Anant Murthy on making it as a US biotech in Europ...

Alnylam’s European head of market access and GM of mid-size markets, Anant Murthy, shares his perspective on how a US biotech can adapt to the many unique challenges of the EU market.

Views & Analysis

Is behavioural science the new capability every pharma company should be building

Behaviour science: the new capability every pharma company s...

Mark Lightowler takes a look at why medical interventions are evolving beyond drugs to also help patients change behaviours that impact their disease.

White Papers

Customer experience in healthcare - a strategic priority for...

Customer experience (CX) is widely, and rightly, acknowledged to be one of the pharmaceutical industry’s top strategic priorities.

Views & Analysis

What HCPs think about virtual congresses

With most of the world being in lockdown we are all looking for new ways to continue to lead our lives as normally as possible, from personal Zoom quiz nights with family to gathering marke

MSD’s David Peacock on moving UK healthcare forward

The enduring innovation and behaviour changes from COVID-19

Alnylam’s Anant Murthy on making it as a US biotech in Europ...

Behaviour science: the new capability every pharma company s...

Customer experience in healthcare - a strategic priority for...

What HCPs think about virtual congresses

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Views & Analysis

Editor's Picks